ARG1 and neoplasm: For these reasons, in cancer immunotherapy studies, the effects of both deprivation and supplementation of Arg have been tested, the former on the assumption that tumors may be Arg auxotrophic, and the latter in an effort to counteract the detrimental effect of ARG1-competent, tumor-associated MDSCs on the host antitumor response.